MedTrace Logo

A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants

NCT06270511 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-07-10

No results posted yet for this study

Summary

The aim of this study is to investigate different formulations of S-337395.

Conditions

  • Healthy Volunteers

Interventions

DRUG

S-337395

Administered as an oral suspension.

DRUG

Placebo

Administered as an oral suspension.

Sponsors & Collaborators

  • Shionogi

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-13
Primary Completion
2024-05-30
Completion
2024-06-19
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06270511 on ClinicalTrials.gov